4Tissue: what changed
Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
4Tissue
Largest movements
- Cash -€649,507
down €649,507 (-84.2%), from €771,689 to €122,182
mainly Investment in fixed assets (net) (-€1.3m) and Net result for the year (-€727,036)
- Receivables within one year +€483,120
up €483,120 (+194.3%), from €248,624 to €731,744
- Intangible fixed assets +€456,971
up €456,971 (+360.4%), from €126,803 to €583,774
- Current investments +€355,222
new in 2025: €355,222
- Receivables after one year +€235,774
up €235,774 (+51.8%), from €455,450 to €691,224
- Contributions +€999,800
up €999,800 (+109.3%), from €915,000 to €1.9m
- Profit (loss) carried forward -€727,036
down €727,036 (-212.4%), from -€342,288 to -€1.1m
- Accrued charges and deferred income +€547,592
up €547,592 (+55.5%), from €987,090 to €1.5m
- Trade debts +€100,104
up €100,104 (+245.0%), from €40,865 to €140,970
- Tax, wage and social debts +€34,243
up €34,243 (+961.6%), from €3,561 to €37,804
- Depreciation +€600,922
up €600,922 (+318.7%), from €188,531 to €789,452
- Gross operating margin +€441,234
up €441,234, from -€113,482 to €327,753
- Staff costs +€277,856
up €277,856 (+872.8%), from €31,834 to €309,690
- Taxes -€28,009
down €28,009 (-231.2%), from -€12,113 to -€40,121
- Financial income +€4,133
up €4,133 (+282.5%), from €1,463 to €5,596
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Cash bridge derived
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €1,604,566 | €2,559,270 | +€954,703 | +59.5% |
| Fixed assets | 21/28 | €126,803 | €650,355 | +€523,552 | +412.9% |
| Intangible fixed assets | 21 | €126,803 | €583,774 | +€456,971 | +360.4% |
| Tangible fixed assets | 22/27 | - | €66,581 | +€66,581 | |
| Plant, machinery and equipment | 23 | - | €66,581 | +€66,581 | |
| Current assets | 29/58 | €1,477,763 | €1,908,915 | +€431,152 | +29.2% |
| Amounts receivable after more than one year | 29 | €455,450 | €691,224 | +€235,774 | +51.8% |
| Other amounts receivable | 291 | €455,450 | €691,224 | +€235,774 | +51.8% |
| Amounts receivable within one year | 40/41 | €248,624 | €731,744 | +€483,120 | +194.3% |
| Other amounts receivable | 41 | €248,624 | €731,744 | +€483,120 | +194.3% |
| Current investments | 50/53 | - | €355,222 | +€355,222 | |
| Cash at bank and in hand | 54/58 | €771,689 | €122,182 | -€649,507 | -84.2% |
| Deferred charges and accrued income | 490/1 | €1,999 | €8,543 | +€6,544 | +327.3% |
| Total equity and liabilities | 10/49 | €1,604,566 | €2,559,270 | +€954,703 | +59.5% |
| Equity | 10/15 | €572,712 | €845,476 | +€272,764 | +47.6% |
| Contributions | 10/11 | €915,000 | €1,914,800 | +€999,800 | +109.3% |
| Profit (loss) carried forward | 14 | -€342,288 | -€1,069,324 | -€727,036 | -212.4% |
| Amounts payable | 17/49 | €1,031,854 | €1,713,793 | +€681,939 | +66.1% |
| Amounts payable within one year | 42/48 | €44,764 | €179,111 | +€134,347 | +300.1% |
| Trade debts | 44 | €40,865 | €140,970 | +€100,104 | +245.0% |
| Suppliers | 440/4 | €40,865 | €140,970 | +€100,104 | +245.0% |
| Taxes, remuneration and social security | 45 | €3,561 | €37,804 | +€34,243 | +961.6% |
| Remuneration and social security | 454/9 | €3,561 | €37,804 | +€34,243 | +961.6% |
| Other amounts payable | 47/48 | €337 | €337 | = | 0.0% |
| Accrued charges and deferred income | 492/3 | €987,090 | €1,534,682 | +€547,592 | +55.5% |
| Remuneration, social security and pensions | 62 | €31,834 | €309,690 | +€277,856 | +872.8% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €188,531 | €789,452 | +€600,922 | +318.7% |
| Other operating charges | 640/8 | €899 | €578 | -€321 | -35.7% |
| Gross operating margin | 9900 | -€113,482 | €327,753 | +€441,234 | |
| Operating profit (loss) | 9901 | -€334,746 | -€771,968 | -€437,222 | -130.6% |
| Financial income | 75/76B | €1,463 | €5,596 | +€4,133 | +282.5% |
| Recurring financial income | 75 | €1,463 | €5,596 | +€4,133 | +282.5% |
| Financial charges | 65/66B | €44 | €785 | +€742 | +1704.9% |
| Recurring financial charges | 65 | €44 | €785 | +€742 | +1704.9% |
| Profit (loss) for the period before taxes | 9903 | -€333,326 | -€767,157 | -€433,831 | -130.2% |
| Income taxes | 67/77 | -€12,113 | -€40,121 | -€28,009 | -231.2% |
| Profit (loss) for the period | 9904 | -€321,213 | -€727,036 | -€405,823 | -126.3% |
| Profit (loss) for the period to be appropriated | 9905 | -€321,213 | -€727,036 | -€405,823 | -126.3% |
Source: filed annual accounts (NBB), fiscal years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 7 October 2026 via checked.be.